Oppenheimer Asset Management Inc. Has $4.57 Million Stake in Exponent, Inc. (NASDAQ:EXPO)

Oppenheimer Asset Management Inc. decreased its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 2.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 39,620 shares of the business services provider’s stock after selling 942 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Exponent were worth $4,567,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. Comerica Bank lifted its position in Exponent by 8.7% in the first quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock worth $19,112,000 after purchasing an additional 18,429 shares during the period. Silvercrest Asset Management Group LLC lifted its holdings in shares of Exponent by 6.8% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 276,500 shares of the business services provider’s stock worth $22,864,000 after acquiring an additional 17,496 shares during the period. Raymond James & Associates boosted its position in shares of Exponent by 4.1% during the 2nd quarter. Raymond James & Associates now owns 487,035 shares of the business services provider’s stock valued at $46,327,000 after acquiring an additional 19,051 shares in the last quarter. Vanguard Group Inc. increased its stake in Exponent by 5.8% in the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after acquiring an additional 291,047 shares during the period. Finally, &PARTNERS bought a new stake in Exponent in the second quarter valued at about $501,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

Insider Transactions at Exponent

In related news, Director Paul R. Johnston sold 7,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $103.83, for a total transaction of $726,810.00. Following the completion of the sale, the director now directly owns 80,742 shares of the company’s stock, valued at $8,383,441.86. This trade represents a 7.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now owns 5,871 shares in the company, valued at $565,494.72. The trade was a 15.04 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,039 shares of company stock valued at $2,291,286. 2.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Separately, Truist Financial restated a “buy” rating and set a $120.00 price target (up previously from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Price Performance

Shares of EXPO stock opened at $97.40 on Friday. The stock’s fifty day simple moving average is $107.23 and its 200 day simple moving average is $101.97. Exponent, Inc. has a one year low of $68.70 and a one year high of $115.75. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 47.05 and a beta of 0.69.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.15%. The ex-dividend date is Friday, December 6th. Exponent’s payout ratio is 54.11%.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.